[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354139-105":59,"doc-detail-354139-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-value-of-impaired-vocal-cord-mobility-in-t2n0-glottic-cancer-treated-with-imrt","Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT","","Objectives assess the prognostic importance of impaired vocal cord mobility (VCM) in T2N0 glottic cancer. Methods retrospectively review patients with T2N0 treated with partial laryngeal IMRT (2009–2021) and compare outcomes with T1N0 and T3N0 cohorts. Results include 642 cases and show stepwise worsening of locoregional failure, disease-free survival, and overall survival from T1N0 to T2-Normal-VCM to T2-Impaired-VCM and T3N0; multivariable analysis confirms higher LRF and reduced DFS/OS with impaired VCM. Conclusions support adverse prognosis and future T2a/T2b subdivision, with prospective validation needed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-value-of-impaired-vocal-cord-mobility-in-t2n0-glottic-cancer-treated-with-imrt/354139/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-value-of-impaired-vocal-cord-mobility-in-t2n0-glottic-cancer-treated-with-imrt/354139.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about T2N0 glottic cancer?","Question",{"text":112,"@type":113},"It evaluates whether impaired vocal cord mobility (VCM) has prognostic value in T2N0 glottic cancer treated with IMRT.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients grouped for comparison in the analysis?",{"text":117,"@type":113},"The study compared T1N0, T2N0 with normal VCM (T2-Normal-VCM), T2N0 with impaired VCM (T2-Impaired-VCM), and T3N0 groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results show about locoregional failure and survival?",{"text":121,"@type":113},"Locoregional failure, disease-free survival, and overall survival worsened stepwise from T1N0 to T2-Normal-VCM to T2-Impaired-VCM and T3N0, with impaired VCM associated with higher LRF and lower DFS/OS in multivariable analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354139,1791179580,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","The Laryngoscope   \n ORIGINAL REPORT  OPEN ACCESS   \nPrognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT  \nAlexander Rühle1  | Ranjan Subramani1 | Jie Su2 | Brian O'Sullivan1,3 | John N. Waldron1,3 | Andrew Hope1 | Andrew Bayley1 | Andrew McPartlin1 | Nauman Malik1 | Scott V. Bratman1 | Ali Hosni1 | John Kim1 | Ian Witterick3,4 | John R. de Almeida3 | Christopher Yao3 | Anna Spreafico5 | C. Jillian Tsai1 | Li Tong1 | Wei Xu2 | Shao Hui Huang1,3 | Ezra Hahn1  \n1Department of Radiation Oncology, The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada | 2Department of Biostatistics, The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada | 3Department of Otolaryngology-Head & Neck Surgery, The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada | 4Department of Otolaryngology-Head and Neck Surgery, Sinai Health System, Mount Sinai Hospital,  \nUniversity of Toronto, Toronto, Canada | 5Division of Medical Oncology, The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada Correspondence: Shao Hui Huang ([shaohui.huang@uhn.ca](shaohui.huang@uhn.ca)) | Ezra Hahn ([ezra.hahn@uhn.ca](ezra.hahn@uhn.ca))  \nReceived: 3 November 2025 | Revised: 14 January 2026 | Accepted: 26 January 2026  \nKeywords: glottic cancer | outcomes | radiotherapy | TNM staging | vocal cord mobility  \nABSTRACT  \nObjectives: To evaluate the prognostic importance of impaired vocal cord mobility (VCM) in T2N0 glottic cancer.  \nMethods: All patients with T2N0 glottic cancer treated with partial laryngeal IMRTin 2009–2021 in our institution were retrospectively reviewed. For comparison, cohorts with T1N0 and T3N0 disease were also included. Locoregional failure (LRF), disease-free survival (DFS), and overall survival (OS) were compared among T1N0, T2N0 with normal VCM (T2-Normal-VCM), T2N0 with impaired VCM (T2-Impaired-VCM), and T3N0 groups. Multivariable analysis (MVA) assessed the prognostic value of VCM within the T2N0 group. Results: A total of 642 cases were included: 288 T1N0, 224 T2N0 (147T2-Normal-VCM, 77 T2-Impaired-VCM), and 130 T3N0 . Median follow-up was 5.0 years (IQR 3.4–6.2) . Five-year LRF for T1N0, T2-Normal-VCM, T2-Impaired-VCM, and T3N0 were 4%(95% CI 2–6), 9%(5–15), 27%(17–38), and 35%(27–44), respectively. Corresponding DFS was 83%(78–88), 80%(73–87), 55%(45–68), and 50%(41–60), while OS was 85%(80–90), 86%(80–92), 71%(61–83), and 59%(50–69), respectively. In T2N0, MVA confirmed that impaired VCM was associated with higher LRF (aHR 3.72 [95% CI 1.79–7.71], p \u003C 0.001), lower DFS (aHR 2.74 [1.68–4.45], p \u003C 0.001), and lower OS (aHR 2.07 [1.17–3.67], p = 0.013) .  \nConclusions: In this contemporary cohort, LRF rates increased stepwise from T1N0 to T2-Normal-VCM, T2-Impaired-VCM, and T3N0 glottic cancer. Within T2N0 disease, impaired VCM is an adverse prognostic factor, supporting subdivision into T2a (normal VCM) and T2b (impaired VCM) in future TNM revisions. Prospective studies are warranted to assess whether treatment intensification can improve outcomes for T2-Impaired-VCM disease.  \nLevel of Evidence: 3.  \n1 | Introduction  \nLaryngeal and hypopharyngeal cancer are the only head and neck cancers (HNCs) in which a functional variable, “vocal cord mobility” (VCM), is included as a cT category modifier  \nin the UICC/AJCC TNM classification. In TNM8, glottic cancer is classified as T2 if there is supraglottic extension, subglottic extension, or impaired VCM, without further subdivision. However, several studies suggest these three T2 modifiers do not share equal prognostic weight, with impaired VCM potentially  \n\n| Shao Hui Huang and Ezra Hahn contributed equally. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.\u003Cbr>© 2026","cbCaioUlT4U1Bc8L","https://ap.wps.com/l/cbCaioUlT4U1Bc8L","pdf",2024719,"English","# Introduction\n## Study objective and rationale\n## Methods and patient cohorts\n## Outcomes (LRF, DFS, OS)\n## Multivariable analysis\n## Conclusions and implications","[{\"question\":\"What question does the study address about T2N0 glottic cancer?\",\"answer\":\"It evaluates whether impaired vocal cord mobility (VCM) has prognostic value in T2N0 glottic cancer treated with IMRT.\"},{\"question\":\"How were patients grouped for comparison in the analysis?\",\"answer\":\"The study compared T1N0, T2N0 with normal VCM (T2-Normal-VCM), T2N0 with impaired VCM (T2-Impaired-VCM), and T3N0 groups.\"},{\"question\":\"What do the results show about locoregional failure and survival?\",\"answer\":\"Locoregional failure, disease-free survival, and overall survival worsened stepwise from T1N0 to T2-Normal-VCM to T2-Impaired-VCM and T3N0, with impaired VCM associated with higher LRF and lower DFS/OS in multivariable analysis.\"}]","Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT | PDF",1790109205,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d50c2630b971d37d891fd9eac8f86f58.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b189ec8f3f11d6fc61444b8e6382e669.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8bae901767612222fcc631f0de22c0f.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81af5c497635bd33bbfbf924684ba3a8.webp",980,1287]